This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Macular Degeneration  • Quality of Life  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Jan Mitchell, PhD

Arch Ophthalmol. 2007;125(9):1266-1268.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Wet (also called neovascular) macular degeneration is a chronic, progressive eye condition that mainly affects people aged 60 years and older. It is estimated that the disease affects around 2 million people across Europe¹ and 1.25 million in the United States.² Wet macular degeneration is the leading cause of blindness in people older than 65 years in the developed world. A number of treatments are available, but they are not suitable for all cases of wet macular degeneration. Where treatment is appropriate, it does not cure the condition but rather halts or limits its progress, though newer treatments may bring about improvements for some patients. Macular degeneration is usually bilateral and its impact on patients can be devastating.³

The psychosocial, emotional, and functional effects of macular degeneration have been variously investigated in a number of studies. Findings have indicated that macular degeneration has a negative impact . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Burden and Health Care Resource Utilization in Neovascular Age-Related Macular Degeneration: Findings of a Multicountry Study
Gisèle Soubrane, Alan Cruess, Andrew Lotery, Daniel Pauleikhoff, Jordi Monès, Xiao Xu, Gergana Zlateva, Ronald Buggage, John Conlon, and Thomas F. Goss
Arch Ophthalmol. 2007;125(9):1249-1254.
ABSTRACT | FULL TEXT